Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins

502 indexed citations
published 2002

Countries where authors are citing Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins

Specialization
Citations

This map shows the geographic impact of Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins more than expected).

Fields of papers citing Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins.

About Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins

This paper, published in 2002, received 502 indexed citations . Written by Louise E. Reynolds, Lorenza Wyder, Julie C. Lively, Daniela Taverna, Stephen D. Robinson, Xiaozhu Huang, Dean Sheppard, Richard O. Hynes and Kairbaan Hodivala‐Dilke covering the research area of Molecular Biology, Immunology and Allergy and Cancer Research. It is primarily cited by scholars working on Immunology and Allergy (331 citations), Molecular Biology (319 citations) and Cancer Research (128 citations). Published in Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/nm0102-27.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026